The action of moxifloxacin in the elderly community-acquired pneumonia
Abstract
Objective To evaluate the effectiveness and safety of moxifloxacin in the elderly community-acquired pneumonia.Methods The patients with elderly community-acquired pneumonia who were in hospital from January 2008 to March 2009 were randomly selected and divided into a treatment group(n=20)and a contrast group(n=20).The treatment group were given moxifloxacin 400 mg intravenous drip qd and the contrast group were given 300 mg of levofloxacin qd.The period of the treatment was two weeks.Clinical effects and adverse reactions were observed.Results The effective rates of the treatment group were 87.50%,the rates of bacterial clearance were 82.75%.The rates of adverse reactions were 12.50%.Conclusion Moxifloxacin in the elderly community-acquired pneumonia has high effective rates and less adverse reactions.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.